14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
PMI vs KIDS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Picard Medical, Inc. (PMI) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (48.4/100 HOLD vs. 45.1/100 HOLD) after splitting the core matrix 5–4 (led by Valuation Multiples), while KIDS wins 4–1 across the 6-pillar growth and valuation breakdown. PMI trades at $6.30 (N/M Forward P/E, -248.1% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin).
Growth vs. Quality Trade-Off: PMI earns the overall head-to-head edge with a stronger Unified Composite Score (48.4/100 HOLD vs. KIDS 45.1/100 HOLD) and 54.06β · 134% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMI vs KIDS. Trailing 12-month operating profitability (PMI -248.1% vs KIDS -8.2%) and valuation multiples (PMI N/M vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment82.0% of Rev ($217M)
90D Engineering Disclosures0 Published
Investor FAQ PMI vs KIDS Key Questions & Quantitative Answers
As of Nov 19, 2026, Picard Medical, Inc. (PMI) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (48.4/100 HOLD vs. 45.1/100 HOLD) after splitting the core matrix 5–4 (led by Valuation Multiples), while KIDS wins 4–1 across the 6-pillar growth and valuation breakdown. PMI trades at $6.30 (N/M Forward P/E, -248.1% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin). Growth vs. Quality Trade-Off: PMI earns the overall head-to-head edge with a stronger Unified Composite Score (48.4/100 HOLD vs. KIDS 45.1/100 HOLD) and 54.06β · 134% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
KIDS leads the Growth & Scale pillar: PMI posts +38.6% YoY revenue growth and +0.0% YoY earnings growth on $6.3M TTM revenue (18.6% gross margin, -248.1% operating margin), compared with KIDS at +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin). On trailing 12-month operating scale, PMI generates $6.3M in USD-normalized revenue versus $264M for KIDS. In operating R&D and SG&A reinvestment, PMI deploys N/A (0 90-day corporate R&D disclosures) versus 82.0% of Rev ($217M) (0 disclosures) for KIDS.
PMI screens cheaper on headline valuation multiples. PMI trades at N/M Forward P/E, 2.9x Trailing P/E, N/M PEG, and 3.2x EV/Revenue (unreported FCF margin), whereas KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMI (0.0% ROE) versus KIDS (-9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, PMI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (54.06β · 134% Vol realized risk). By comparison, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.